Hepatobiliary & Pancreatic Diseases International, an esteemed journal published by Elsevier, stands as a vital resource within the field of gastroenterology and hepatology. Established in 2002, this journal has developed a significant reputation, currently ranked in the second quartile (Q2) in both categories as of 2023, showcasing its commitment to high-quality research and clinical studies. Based in Singapore, Hepatobiliary & Pancreatic Diseases International serves as an essential platform for researchers, clinicians, and healthcare professionals to share innovative findings, therapeutic approaches, and advancements in the understanding of hepatobiliary and pancreatic diseases. Although the journal does not currently offer Open Access, its rigorous peer-review process ensures that published articles maintain the highest scientific standards, fostering knowledge dissemination among the global research community. With a convergence period extending to 2024, this journal continues to play a pivotal role in enhancing the understanding and treatment of complex gastrointestinal conditions, making it a must-read for anyone engaged in this dynamic field.

DISEASES OF THE ESOPHAGUS is a prestigious, peer-reviewed journal published by Oxford University Press Inc, focusing on the clinical and translational aspects of esophageal diseases. With an ISSN of 1120-8694 and an E-ISSN of 1442-2050, this journal has cultivated a reputation for excellence since its inception in 1988. Its impact is underscored by its prestigious Q1 ranking in both Gastroenterology and Medicine (miscellaneous) categories as of 2023, positioning it among the top tier of journals within these fields. The journal's scholarly contributions span a wide range of topics relevant to researchers, healthcare professionals, and clinical practitioners, emphasizing advancement in diagnosis and treatment of esophageal conditions. Although currently not an open-access journal, its content is widely accessible through institutional libraries, ensuring that valuable research reaches the hands of those dedicated to enhancing patient care. As it continues publishing through 2024, DISEASES OF THE ESOPHAGUS remains an essential resource for those engaged in understanding and managing esophageal health.

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.

GASTROINTESTINAL ENDOSCOPY, published by MOSBY-ELSEVIER, stands as a leading journal in the fields of gastroenterology and radiology, boasting an impressive impact factor that reflects its esteemed position within the academic community. Established in 1965 and set to continue through 2024, this journal is critical for disseminating high-quality research that informs clinical practice and enhances patient care. With a robust Scopus ranking — 25th out of 333 in Radiology, Nuclear Medicine and Imaging, and 15th out of 167 in Gastroenterology — it proudly maintains a #1 quartile status in both disciplines as of 2023. While the journal does not offer open access, it remains invaluable for researchers, professionals, and students seeking to stay ahead in the rapidly evolving fields of gastrointestinal pathology and innovative endoscopic procedures. Its comprehensive scope encompasses technological advancements, clinical studies, and critical reviews, making it a vital resource for advancing knowledge and supporting professional development.

Seminars in Colon and Rectal Surgery is a peer-reviewed journal published by W B Saunders Co-Elsevier Inc, focused on the dynamic fields of gastroenterology and surgical practices related to colon and rectal health. Established in 1996, the journal has evolved to serve as a crucial platform for disseminating innovative research, clinical findings, and thorough reviews relevant to colorectal surgery. It holds an impact factor that reflects its commitment to advancing knowledge in the field, currently ranking in Q4 in Gastroenterology and Q3 in Surgery as of 2023. Researchers and practitioners alike benefit from the latest insights, addressing pivotal topics, treatment paradigms, and surgical techniques that shape modern surgical practices. With a continued focus on enhancing the quality of care in gastrointestinal health, Seminars in Colon and Rectal Surgery plays an essential role in fostering academic dialogue and clinical expertise, making it an invaluable resource for students, professionals, and researchers passionate about advancing the field.

Colorectal Disease, published by Wiley, is a premier journal dedicated to advancing research and clinical practice in the field of gastroenterology. With an impressive impact factor and ranked in the Q1 category for Gastroenterology according to 2023 metrics, this journal serves as a vital platform for researchers, clinicians, and students alike. Covering a diverse range of topics from clinical trials to innovative treatment practices, Colorectal Disease strives to disseminate high-quality research that informs effective treatment strategies for colorectal conditions. Since its inception in 1999, the journal has established itself as an essential resource, with its contributions placing it in the 76th percentile among its peers in Scopus rankings. While the journal is not open access, it provides a wealth of knowledge and insights that are crucial for anyone involved in gastrointestinal research and practice. The journal’s address is 111 River Street, Hoboken, NJ 07030-5774, United Kingdom, where it continues to champion excellence in colorectal health research until the end of 2024.

Gastroenterology Nursing is a pivotal peer-reviewed journal dedicated to advancing the field of nursing within gastroenterology, published by Lippincott Williams & Wilkins. Since its inception in 1989, this journal has become an essential resource for nursing professionals seeking to enhance their knowledge and practices in managing gastrointestinal health. With an ISSN of 1042-895X and an E-ISSN of 1538-9766, it serves as a scholarly platform for sharing innovative research, clinical studies, and comprehensive reviews addressing critical nursing issues in gastroenterology. Despite its current Q3 ranking in both Advanced and Specialized Nursing and Gastroenterology, and a Q4 ranking in Medicine (miscellaneous), the journal continues to strive towards improving its influence and reach within the academic community. As part of an ongoing commitment to elevate nursing excellence, the journal publishes a variety of articles aimed at facilitating informed practice and contributing to professional development. The absence of a specific Open Access model does not diminish its value, as it remains a key resource for those dedicated to enhancing patient care in gastrointestinal nursing.

DIGESTIVE AND LIVER DISEASE is a prominent journal published by Elsevier Science Inc, dedicated to advancing the field of gastroenterology and hepatology. With an ISSN of 1590-8658 and an E-ISSN of 1878-3562, this journal has established itself as a significant resource within the academic community, especially considering its Q2 ranking in both gastroenterology and hepatology categories as of 2023. Spanning from 2000 to 2024, the journal presents a diverse array of peer-reviewed articles, clinical studies, and review papers that explore the latest advancements and research findings in digestive and liver diseases. The journal's robust impact, reflected in its Scopus rankings—40th out of 167 in gastroenterology and 28th out of 82 in hepatology—highlights its critical role in shaping practices and understanding in these vital areas of medicine. With open access options available, DIGESTIVE AND LIVER DISEASE aims to make high-quality research accessible to a wider audience, thereby encouraging collaboration and innovation. Researchers, healthcare professionals, and students alike will find valuable insights into the complex mechanisms, diagnostics, and therapeutic strategies pertinent to digestive and liver health.

INFLAMMATORY BOWEL DISEASES is a premier journal published by Oxford University Press, Inc., dedicated to advancing research within the fields of gastroenterology and immunology. With an impressive impact factor reflecting its status as a Q1 category journal in both gastroenterology and immunology and allergy, it ranks 17th out of 167 in gastroenterology and 53rd out of 233 in immunology, underscoring its influence and authority within the scientific community. Since its inception in 1995 and continuing through to 2024, the journal has become an essential resource for researchers, healthcare professionals, and students, serving as a platform for the latest findings in the diagnosis, treatment, and management of inflammatory bowel diseases. While the journal operates under a subscription-based model, it is recognized for its rigorous peer-review process and commitment to publishing high-caliber, impactful studies that contribute significantly to understanding and treating these complex conditions.